A less technical but very engaging conversation that answers many questions a biotech entrepreneur might have.

Some of the topics we discussed:

1. To what extent should biotech investors diversify?
2. How should entrepreneurs think like an investor?
3. How should entrepreneurs create the Wow Slide, especially regarding deal values?
4. How does Luis validate or assure that the probability of a liquidity event increases?
5. Game Theory: Does it work in the real world, given that we are irrational by nature?
6. The market size conundrum: If you have a disruptive drug, you only know the market ex-post. How do you evaluate market size and pricing early?

…and many more…